Although the state won FDA approval for its importation program in January 2024, it has yet to implement the program.
Medical spas and wellness clinics are operating on the edge of existing regulatory frameworks and it’s a risk to American patients.
Between November 2022 and June 2023, Amarvel Biotech sold over 200 kilograms of precursor chemicals to U.S. buyers with full knowledge that they would be used to make fentanyl.
Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.
The warning letter was one of about 100 is a new focus on deceptive direct-to-consumer drug advertisements.
The “green list” will help protect patients from unreliable, illegally compounded GLP-1s and simplify screening for border security.
PSM led a coalition of organizations urging leaders of the Senate HELP and House Energy and Commerce committees to help strengthen the FDA’s ability to protect Americans from unsafe and counterfeit medicines and medical products.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
Regulatory confusion leaves med spa patients at risk. Learn more.
Gaps in FDA oversight of 503B compounding facilities put patients at risk.
More fake Ozempic in the U.S. Learn more.
Click the images below to see more recent videos.